Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, March 8, 2023
[ Wed, Mar 08th 2023
] - WOPRAI
[ Wed, Mar 08th 2023
] - WOPRAI
[ Wed, Mar 08th 2023
] - WOPRAI
[ Wed, Mar 08th 2023
] - WOPRAI
[ Wed, Mar 08th 2023
] - WOPRAI
[ Wed, Mar 08th 2023
] - WOPRAI
[ Wed, Mar 08th 2023
] - WOPRAI
[ Wed, Mar 08th 2023
] - WOPRAI
[ Wed, Mar 08th 2023
] - WOPRAI
[ Wed, Mar 08th 2023
] - WOPRAI
[ Wed, Mar 08th 2023
] - WOPRAI
[ Wed, Mar 08th 2023
] - WOPRAI
[ Wed, Mar 08th 2023
] - WOPRAI
[ Wed, Mar 08th 2023
] - WOPRAI
[ Wed, Mar 08th 2023
] - WOPRAI
[ Wed, Mar 08th 2023
] - WOPRAI
[ Wed, Mar 08th 2023
] - WOPRAI
[ Wed, Mar 08th 2023
] - WOPRAI
[ Wed, Mar 08th 2023
] - WOPRAI
[ Wed, Mar 08th 2023
] - WOPRAI
[ Wed, Mar 08th 2023
] - WOPRAI
[ Wed, Mar 08th 2023
] - WOPRAI
[ Wed, Mar 08th 2023
] - WOPRAI
[ Wed, Mar 08th 2023
] - WOPRAI
[ Wed, Mar 08th 2023
] - WOPRAI
[ Wed, Mar 08th 2023
] - WOPRAI
[ Wed, Mar 08th 2023
] - WOPRAI
[ Wed, Mar 08th 2023
] - WOPRAI
[ Wed, Mar 08th 2023
] - WOPRAI
Mara Goldstein Maintained (AUTL) at Strong Buy with Decreased Target to $12 on, Mar 8th, 2023
Mara Goldstein of Mizuho, Maintained "Autolus Therapeutics plc" (AUTL) at Strong Buy with Decreased Target from $18 to $12 on, Mar 8th, 2023.
Mara has made no other calls on AUTL in the last 4 months.
There is 1 other peer that has a rating on AUTL. Out of the 1 peers that are also analyzing AUTL, 0 agree with Mara's Rating of Hold.
This is the rating of the analyst that currently disagrees with Mara
- Gil Blum of "Needham" Reiterated at Strong Buy and Held Target at $7 on, Tuesday, March 7th, 2023
